SWOT Analysis for Vivo Bio Tech Ltd.

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Undervalued Growth Stocks
PEG lower than Industry PEG
Affordable Stocks - Stocks with Good Trendlyne Valuation Score
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Top Gainers
Volume Shockers

Promoter decreasing their shareholding
Companies with growing costs YoY for long term projects
Fall in Quarterly Revenue and Net Profit (YoY)
Weak Momentum: Price below Short, Medium and Long Term Averages
Stocks Underperforming their Industry Price Change in the Quarter

Stocks in PE Buy Zone with Reasonable Durability Score, and Rising Momentum Score
Rising Delivery Percentage Compared to Prev Day
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)

Vivo Bio Tech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats